Virus reactivation in acute and long COVID-19
Cole Maguire(The University of Texas at Austin), Simon van Haren, JAMES ABRAHAM, Annmarie Hoch(Boston Children's Hospital), Arthur Viodé(Boston Children's Hospital), Benoit Fatou(Boston Children's Hospital), Arash Nemati Hayati, Carly E. Milliren(Boston Children's Hospital), Hoang Van Phan(University of California, San Francisco), Nadine Rouphael(Emory University), Mitchell Cooney, Kerstin Westendorf(La Jolla Institute for Immunology), Alvin T. Kho(The Coordinating Center), Naresh Doni Jayavelu(Benaroya Research Institute), Claudia Lentucci(Boston Children's Hospital), Brenda Barton(Boston Children's Hospital), Ravi Dandekar(University of California, San Francisco), Tomasz Jancsyk, Brinkley Morse(Baylor College of Medicine), Albert Marisa(Emory University), Serena Lee, Robert Bryant, Scott Presnell, Randi Vita, Kinga K. Smolen(Boston Children's Hospital), Azlann Arnett, Harry Pickering(University of California, Los Angeles), Victoria Chu(University of California, San Francisco), Mehmet Saluvan, IMPACC Network, Hanno Steen(Boston Children's Hospital), Bernard Kohr, Ana C. Chang, Caitlin Syphurs, James A. Overton, Ofer Levy(Broad Institute), Lindsey B. Rosen, Maimouna D. Murphy, Shanshan Liu, Tanzia Shaheen, Steven M. Holland, Meagan Karoly, Patrick van Zalm, Abigail Glascock(Chan Zuckerberg Initiative (United States)), Joann Diray-Arce(Boston Children's Hospital), Tatyana Vaysman, Jing Chen(Boston Children's Hospital), Kerry McEnaney
Cited by 1
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease
|Nature Medicine|2020|445